June 25, 2009 โ€“ Terumo Interventional Systems today announced the expansion of its Pinnacle R/O II Radiopaque Marker Introducer Sheaths to provide a broader selection of marker band sheath sizes for vascular access, extending the range of interventional procedures that can be performed.

June 25, 2009 โ€“ Abiomed Inc. yesterday announced the successful implant of its AbioCor Total Replacement Heart, performed at Robert Wood Johnson University Hospital by Mark Anderson, M.D., associate professor of surgery at UMDNJ-Robert Wood Johnson Medical School and chief of the section of cardiac surgery at both the medical school and Robert Wood Johnson University Hospital.

June 25, 2009 โ€“ Smiths Medical today launched its new BCI SPECTRO2 Pulse Oximetry Portfolio, designed for a variety of patient care settings.

June 24, 2009 โ€“ Data presented today as a Hot Line session at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic Inc., shows that the Medtronic Reveal XT Insertable Cardiac Monitor (ICM) reliably identifies patients with AF (sensitivity of 96.1 percent) and correctly confirms the absence of AF in patients (negative predictive value of 97.4 percent).

June 24, 2009 โ€“ CorNova Inc. said this week it received CE mark approval for its Valecor Platinum Coronary Stent System, a next generation cobalt-chromium bare metal stent.

June 24, 2009 โ€“ CircuLite Inc. today announced the publication of positive data from its ongoing CE mark clinical trial for the Synergy Pocket Micropump for chronic heart failure in the Journal of the American College of Cardiology.

June 24, 2009 - NDS Surgical Imaging (NDSsi) announced it acquired a wireless video technology that extends its current imaging capabilities in the operating room (OR) and beyond.

By integrating this new technology with its medical visualization and informatics platforms, the company plans to develop a compelling array of wireless solutions for surgical, endoscopy and interventional suites.

June 23, 2009 - Today, Medtronic Inc. announced the first worldwide enrollments in the MORE-CARE (Monitoring Resynchronization in Cardiac Patients) trial, which will compare two disease management strategies for heart failure patients treated with an implantable device for cardiac resynchronization therapy.


The focus on balloon angioplasty largely slipped from the interventional limelight a decade ago after the introduction of stents, but today there is some renewed interest with the advent of new balloon technology.

Subscribe to
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now